The Second Affiliated Hospital Of Shandong First Medical University

This study tests a combination of two immunotherapy drugs (iparomlimab and tuvonralimab) plus a targeted therapy (lenvatinib) and a liver-directed procedure (TACE) in 41 people with advanced hepatocellular carcinoma, a type of liver cancer. The goal is to see if this mix can dela…

This study tests a drug called trilaciclib given before chemotherapy to protect bone marrow in people with advanced bile duct or pancreatic cancer. The goal is to reduce serious side effects like low white blood cell counts, which can lead to infections. About 96 adults will take…